SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-09-020201
Filing Date
2009-04-13
Accepted
2009-04-13 17:58:31
Documents
1
Period of Report
2009-04-01

Document Format Files

Seq Description Document Type Size
1 v146073_ex.html 3  
1 v146073_ex.xml 3 2331
  Complete submission text file 0001144204-09-020201.txt   4157
Mailing Address 2085?B? QUAKER POINT DRIVE QUAKERTOWN PA 18951
Business Address 2085?B? QUAKER POINT DRIVE QUAKERTOWN PA 18951 215-529-6084
Adamis Pharmaceuticals Corp (Issuer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2658 DEL MAR HEIGHTS RD., #555 DEL MAR CA 92014
Business Address
Marguglio David J. (Reporting) CIK: 0001461753 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-26372 | Film No.: 09747348